Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Authors
Keywords
Prostate cancer, Early detection, Overdiagnosis, PSA, Screening
Journal
BMC Medicine
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-02-11
DOI
10.1186/1741-7015-12-26
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The prostate cancer conundrum revisited
- (2012) Ruth Etzioni et al. CANCER
- Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial
- (2012) Andrew Vickers et al. EUROPEAN UROLOGY
- Temporal Trends in Cause of Death Among Swedish and US Men with Prostate Cancer
- (2012) M. M. Epstein et al. JNCI-Journal of the National Cancer Institute
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality-of-Life Effects of Prostate-Specific Antigen Screening
- (2012) Eveline A.M. Heijnsdijk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate-Specific Antigen and Long-Term Prediction of Prostate Cancer Incidence and Mortality in the General Population
- (2011) David D. Ørsted et al. EUROPEAN UROLOGY
- Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
- (2011) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL
- (2010) Yu-Hsuan Shao et al. ARCHIVES OF INTERNAL MEDICINE
- Balancing the harms and benefits of early detection of prostate cancer
- (2010) Pim J. van Leeuwen et al. CANCER
- Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades
- (2010) Ping Tang et al. CANCER
- Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen Screening
- (2010) C. J. Savage et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group
- (2010) A. J. Vickers et al. CLINICAL CANCER RESEARCH
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
- (2009) H. G. Welch et al. JNCI-Journal of the National Cancer Institute
- Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
- (2008) Valeriya Lyssenko et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started